Thrombosis
Thrombosis
Advertisement
Patrick DalyThrombosis | March 21, 2024
VRd was associated with lower rates of venous thromboembolism versus KRd in patients with newly-diagnosed multiple myeloma.
Read More
Patrick DalyThrombosis | January 10, 2024
Intracardiac thrombosis in patients with COVID-19 was associated with increased all-cause and cardiovascular mortality.
Patrick DalyVTE | November 8, 2023
Patients treated for isolated superficial vein thrombosis with anticoagulants still had a "substantial" risk of VTE later on.
Patrick DalyThrombosis | November 8, 2023
Splenomegaly and myeloproliferative disorders increased risk for porto-spleno-mesenteric venous thrombosis after splenectomy.
Patrick DalyThrombosis | October 25, 2023
Edoxaban therapy for 12 months was superior to three-month therapy for preventing venous thromboembolisms and related deaths.
Patrick DalyThrombosis | February 16, 2024
Subclinical leaflet thrombosis appears more common after TAVR versus SAVR, but was not associated with increased stroke risk.
Patrick DalyAtrial Fibrillation | September 6, 2023
Researchers compared the safety and efficacy of two direct oral anticoagulants (DOACs), apixaban and rivaroxaban, ...
Amit Goyal, MDCardioNerds | September 6, 2023
Results from the OCEAN-TAVI registry indicate that a non-antithrombotic strategy may be reasonable following ...
Hady Lichaa, MDPractice Tips With Dr. Lichaa | September 6, 2023
In the second half of a two-part interview, DocWire News partner Hady Lichaa, MD, FACC, FSCAI, FSVM, RPVI, spoke with ...
Hady Lichaa, MDPractice Tips With Dr. Lichaa | September 6, 2023
In part one of a two-part interview, DocWire News partner Hady Lichaa, MD, FACC, FSCAI, FSVM, RPVI, sits down with ...
CardioNerdsCardioNerds | September 6, 2023
It’s another session of CardioNerds Rounds! In these rounds, Dr. Priya Kothapalli (Interventional FIT at University of ...
Rob DillardThrombosis | September 6, 2023
DocWire News recently spoke with Dan Bloomfield, MD, FACC, FAHA, Chief Medical Officer of Anthos Therapeutics. Dr. ...
Patrick DalyThrombosis | September 6, 2023
According to a recent study, the use of short-term, low-dose dabigatran could significantly reduce the risk of bleeding ...
Amit Goyal, MDCardioNerds | September 6, 2023
The clinical impact of subclinical leaflet thrombosis following transcatheter aortic valve replacement (TAVR) is ...
Patrick DalyKidney Transplantation | February 5, 2024
Researchers assessed the UK experience of kidney transplantations from deceased donors who had vaccine-induced immune ...
Patrick DalyAtherosclerotic Disease | October 16, 2023
Researchers reported that "assessing total arterial and venous thrombotic events, not just first events, provides more ...
Patrick DalyITP | September 6, 2023
In a study in Research and Practice in Thrombosis and Haemostasis, researchers examined changes in clinical and platelet ...
Patrick DalyAtrial Fibrillation | September 6, 2023
Researchers explored the optimal duration of triple antithrombotic therapy (TAT) in patients who have atrial ...
Patrick DalyAtrial Fibrillation | September 11, 2023
Therapies that can reduce risk of thrombosis without increasing bleeding complications are needed to improve stroke ...
Patrick DalyVTE | September 6, 2023
Apixaban has been shown to be effective for preventing venous thromboembolism (VTE) in patients with cancer, but is ...
Advertisement
Advertisement
Advertisement
Latest News

July 16, 2024